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Abstract
Introduction Diagnostic strategies based on tracheal aspirates
in patients with severe nursing home-acquired pneumonia have
not previously been evaluated. The objectives of the study were
to investigate, in patients with severe nursing home-acquired
pneumonia, the diagnostic value of quantitative endotracheal
aspirate (QEA) cultures using increasing interpretative cutoff
points, as compared with bronchoalveolar lavage (BAL) and
protected specimen brush (PSB) quantitative cultures.
Methods Seventy-five nursing home patients requiring
mechanical ventilation for suspected pneumonia were studied.
Endotracheal aspirate, PSB, and BAL samples were obtained
consecutively. The diagnostic yield of QEA at thresholds raging
from 103 to 107 colony-forming units (cfu)/ml was assessed by
calculating sensitivities, specificities, and accuracy rates. A
receiver operator characteristic curve for the series of cutoff
points was constructed.
Results Forty-nine patients were diagnosed with pneumonia
either by BAL (≤ 104 cfu/ml) or PSB (≤ 103 cfu/ml). Diagnostic
accuracy of QEA was most favorable at 104 cfu/ml. At this
threshold, endotracheal aspirates coincided with both BAL and
PSB in 30 cases, whereas partial agreement was observed in
14 cases. This resulted in sensitivity and specificity of 90%
(95% confidence interval 78% to 97%) and 77% (95%
confidence interval 56% to 91%), respectively. QEA findings
correlated significantly with both PSB and BAL quantitative
cultures (r  = 0.71 [P  < 0.001] and r  = 0.77 [P  < 0.001],
respectively).
Conclusion QEA may be used as a diagnostic tool to determine
the presence of pneumonia in ventilated patients admitted from
nursing homes when bronchoscopic procedures are not
feasible or available.
Introduction
Nursing home-acquired pneumonia (NHAP) is the leading
cause of death among long-term care patients and is one of
the most common causes of transfer to hospital, where it
accounts for 2% to 18% of patients hospitalized for pneumo-
nia [1,2]. The overall mortality rate among patients requiring
hospitalization for NHAP ranges from 13% to 41% [3,4] and
rises to 57% in those with severe NHAP requiring treatment in
the intensive care unit [5].
Evaluation of the epidemiology of NHAP has been limited by
low bacteriologic yield, poor quality of respiratory specimens,
and potential contamination of the upper respiratory tract
[6,7]. Many nursing home residents have extensive co-morbid-
ities, which increase their risk for colonization with Staphyloco-
ccus aureus or enteric Gram-negative rods. However, there is
no consensus regarding the best diagnostic strategy in these
patients. Clinical features of NHAP are unreliable in establish-
ing accurately the diagnosis of pneumonia in such patients.
Quantitative cultures of protected specimen brush (PSB) and
bronchoalveolar lavage (BAL) specimens have been used to
diagnose severe NHAP [5,8]. However, use of these tech-
niques has been limited by the fact that they are invasive, time
consuming, and require fiberoptic bronchoscopy to be availa-
ble 24 hours per day. Use of quantitative endotracheal aspi-
rates (QEAs) in intubated patients could be viewed as a
simple, fast, and cheap way to identify the responsible micro-
organisms and, combined with knowledge of local
BAL = bronchoalveolar lavage; cfu = colony-forming units; CI, confidence interval; NHAP = nursing home-acquired pneumonia, PSB = protected 
specimen brush; QEA = quantitative endotracheal aspirate.Critical Care    Vol 11 No 3    El Solh et al.
Page 2 of 6
(page number not for citation purposes)
epidemiologic characteristics, can promote early use of appro-
priate antibiotic therapy. However, the accuracy of QEA in this
particular setting has never been assessed. All comparisons of
QEAs with other techniques were conducted in patients with
ventilator-associated pneumonia [9-11]. The aim of the
present study was to compare the diagnostic accuracy of
post-intubation QEA with those of PSB and BAL in patients
requiring mechanical ventilation for suspected NHAP.
Materials and methods
Study population
The study was conducted in a University-affiliated tertiary care
center and was derived from a prospective database devel-
oped over a six year period extending from January 2000 to
December 2005. All nursing home residents presenting to the
emergency room with a diagnosis of pneumonia requiring
mechanical ventilation were eligible for enrollment if a radio-
graphic infiltrate was present that was compatible with pneu-
monia, together with symptoms suggestive of lower
respiratory tract infection, and any two of the following clinical
parameters were present: temperature ≤ 38°C or < 36°C;
white blood cells ≤ 10,000/mm3 or < 4,000/mm3, or > 15%
immature neutrophils (bands) regardless of total peripheral
white blood cell count; and purulent respiratory secretions.
Patients with severe immunosuppression (solid organ trans-
plantation or steroid therapy ≤ 20 mg/day for more than two
weeks), witnessed aspiration, or in whom the pneumonia was
an expected terminal event resulting from metastatic cancer
were excluded. In addition, patients who were receiving anti-
microbial therapy within 72 hours before enrollment were also
excluded. The study was approved by the institutional review
board and, informed consent was obtained from all partici-
pants' next of kin before any invasive procedure was
performed.
Data collection
Data collected on intensive care unit admission included age,
sex, co-morbid illnesses, Charlson Index [12], clinical symp-
toms, and chest radiographic pattern and distribution. The
most deranged readings of vital signs, laboratory data, and
blood gas analysis within the first 24 hours of admission were
also recorded.
Specimen collection
Within two hours of enrollment in the study, all patients under-
went the following protocol. Intravenous midazolam was given
before the procedures. The fraction of inspired oxygen was set
at 90% or more. None of the patients received local anesthet-
ics. A blind endotracheal aspiration sample was obtained first
by sterile means using a 22-inch suction catheter and col-
lected in a mucus collector (Specimen trap, Busse, Haup-
pauge, NY, USA). Subsequently, a bronchoscopic PSB
procedure was performed. A PSB sample was retrieved from
the area of maximal inflammation and purulence, as suspected
based on chest roentgenogram findings. BAL was then per-
formed from the same segment where PSB had been con-
ducted and analyzed according to standard criteria. All
retrieved specimens (endotracheal aspirate, BAL fluid, and
PSB specimen) were sent to the microbiology laboratory
immediately after collection.
Microbiologic processing
Endotracheal aspirate and BAL samples were mechanically
liquefied and homogenized by vortexing for 1 min with glass
beads, followed by centrifuging at 3,000 rpm for 10 min. PSB
samples were aseptically cut and placed in a sterile tube con-
taining 1 ml of 0.9% saline solution and vortexed for 1 min. All
three types of specimens were serially diluted in 0.9% sterile
saline solution. The specimens were then plated into the fol-
lowing agar media: 5% sheep blood, chocolate, and McCo-
nkey agar. All cultures were incubated at 37°C under aerobic
and anaerobic conditions and in a carbon dioxide enriched
atmosphere. Plates were evaluated for growth at 24 and 48
hours and discarded after five days. The number of bacteria in
the original sample was expressed in colony-forming units
(cfu) per milliliter. All micro-organisms were identified using
standard laboratory methods. The threshold for positive cul-
ture defining pneumonia was 103 cfu/ml for PSB or 104 cfu/ml
for BAL, or both. The cutoff points analyzed to establish a pos-
itive result for QEA were 103, 104, 105, 106, and 107 cfu/ml.
Statistical analysis
Descriptive analysis was performed using the NCSS 2000
software (NCSS Statistical Analysis System, Kaysville, UT,
USA). Means were compared using the Student's t-test when
they were normally distributed and the Mann-Whitney test oth-
erwise. Frequencies were compared using a χ2 test or Fisher's
exact test when appropriate. Sensitivity, specificity, false-pos-
itive rate, false-negative rate, and overall accuracy were calcu-
lated using the standard formulae [13]. Quantitative
concordance between techniques was assessed with Pear-
son's correlation coefficient. Graphic representation of diag-
nostic parameters was performed, plotting true-positive
against false-positive percentages to obtain a receiver opera-
tor characteristic curve. All tests were two tailed, and statisti-
cal significance was determined at the 5% level.
Results
Seventy-five patients (45 men and 30 women) were included
in the study. The general characteristics of the study popula-
tion are shown in Table 1. All patients were mechanically ven-
tilated at the time of enrollment. Twenty-one patients had
received at least one dose of antimicrobial agent before bron-
chial samplings.
According to our diagnostic criteria, pneumonia was docu-
mented in 49 (65%) patients. Fifty-six micro-organisms were
isolated at concentrations above the diagnostic thresholds by
either PSB or BAL (Table 2). Polymicrobial infection was
present in three patients. The most frequently isolated bacteriaAvailable online http://ccforum.com/content/11/3/R57
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were Staphylococcus aureus (n = 13), Streptococcus pneu-
moniae (n = 7), and Escherichia coli (n = 7). There was total
agreement in positive bacterial cultures between PSB and
BAL in 33 cases. Twenty-six paired cultures were sterile, and
in 19 of these cases there was exposure to antimicrobial ther-
apy before the invasive procedures were conducted. Discrep-
ancy was noted in 16 cases, which represented 11 BAL-
positive/PSB-negative cases and five BAL-negative/PSB-pos-
itive cases.
The operating characteristics of QEA for detecting the pres-
ence of pneumonia were obtained over a range of values
extending from 103 through to 107 cfu/ml (Table 3 and Figure
1). The sensitivity increased from 18% at the threshold of 107
cfu/ml to 98% at 103 cfu/ml. Conversely, specificity decreased
from 100% at 107 cfu/ml to 35% at 103 cfu/ml. The threshold
of 104 cfu/ml yielded the highest accuracy in diagnosis, with a
sensitivity of 90% (95% confidence interval [CI] 78% to 97%)
and a specificity of 77% (95% CI 56% to 91%). At this thresh-
old, the positive-predictive value was 88% (95% CI 76% to
96%) and the negative predictive value was 80% (95% CI
59% to 93%).
Using 104 cfu/ml as a diagnostic threshold for endotracheal
aspirates, QEA coincided with both BAL and PSB in 30 posi-
tive culture cases. Partial agreement was present in 14 cases;
10 patients had qualitative concordance between QEA and
BAL and four others between QEA and PSB only. In six cases
QEA was below the threshold of 104 cfu/ml for pneumonia
documented by BAL or PSB. Comparisons of bacterial counts
between endotracheal aspirate and BAL and between
endotracheal aspirate and PSB are shown in Figures 2 and 3.
Table 1
Clinical characteristics of the study population
Characteristic Value
Age (years) 72.7 ± 14.9
Sex (male/female) 45/30
Comorbid diseases
Coronary artery disease 15 (20)
Chronic pulmonary 
obstructive disease
31 (41)
Diabetes mellitus 11 (15)
Cerebrovascular accident 27 (36)
Charlson Index 2.3 ± 1.4
Clinical presentation
Fever 59 (79)
Dyspnea 73 (97)
Cough 32 (43)
APACHE II score 27.8 ± 5.7
PaO2/FiO2 241 ± 56
Radiologic score 4.6 ± 1.8
Seventy-five patients were included. Values are expressed as 
number, number (%), or mean ± standard error. APACHE, Acute 
Physiology and Chronic Health Evaluation; FiO2, fractional inspired 
oxygen; PaO2, arterial oxygen tension;
Table 2
Results of quantitative bacterial cultures of BAL and PSB
Pathogen BAL (≤ 104)P S B  ( ≤ 103)
Staphylococcus 
aureus
12 8
Streptococcus 
pneumoniae
64
Streptococcus spp. 5 4
Haemophilus 
influenzae
32
Klebsiella spp. 5 5
Escherichia coli 66
Serratia marcescens 33
Proteus mirabilis 32
Enterobacter ssp. 4 4
Pseudomonas 
aeruginosa
21
BAL, bronchoalveolar lavage; PSB, protected specimen brush.
Table 3
Operating characteristics of the endotracheal aspirates quantitative cultures
Threshold (cfu/ml) Sensitivity (%) Specificity (%) Accuracy (%)
≤ 103 98 (89–100) 35 (17–56) 76 (65–85)
≤ 104 90 (78–97) 77 (56–91) 85 (78–94)
≤ 105 78 (63–88) 84 (65–96) 80 (69–88)
≤ 106 51 (36–66) 92 (75–99) 65 (54–76)
≤ 107 18 (9–32) 100 (87–100) 47 (35–59)
Values in parentheses are 95% confidence intervals.Critical Care    Vol 11 No 3    El Solh et al.
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The correlation coefficients (r) between the quantitative cul-
tures of micro-organisms obtained from endotracheal aspirate
and BAL and from endotracheal aspirate and PSB were 0.77
(P < 0.001) and 0.71 (P < 0.001), respectively.
Discussion
The results of this study indicate that the best overall accuracy
in diagnosing severe NHAP using the endotracheal aspirate
culture technique was obtained at a threshold of 104 cfu/ml. At
this cutoff, there was favorable correlation between endotra-
cheal aspirate and PSB cultures and between endotracheal
aspirate and BAL cultures. These findings suggest that QEA
can be used as a diagnostic tool in severe NHAP where
fiberoptic bronchoscopic techniques are not uniformly availa-
ble or are not practically feasible before the first dose of anti-
microbial therapy.
NHAP has traditionally been approached as a disease that
resembles community-acquired pneumonia rather than noso-
comial pneumonia. The lack of strong epidemiologic data on
microbial etiology has resulted in physicians employing
diagnostic and treatment strategies in NHAP that are similar to
those used in community-acquired pneumonia, and with simi-
lar empiric antibiotic coverage. Following the publication of
several investigations on the microbial spectrum of pathogens
in NHAP [5,14], this approach has shifted drastically toward
classifying NHAP as health care-associated pneumonia.
Because of the substantial mortality associated with both inad-
equate and delayed therapy [5,15,16], the most recent Amer-
ican Thoracic Society guideline [17] advises that the initial
empirical antibiotic coverage for patients hospitalized with
NHAP should have adequate activity against multidrug
resistant pathogens. However, indiscriminate use of broad-
spectrum antibiotics has been implicated in the emergence of
resistant strains in the intensive care unit [18,19]. In response
to this, a consensus has emerged emphasizing the implemen-
tation of de-escalation therapy or discontinuation of antibiotics
once culture results and susceptibility findings are available.
Hitherto, the concept of de-escalation has not been tested in
patients with severe NHAP, in part because of lack of studies
to determine appropriate diagnostic strategies in this segment
of the population.
This is the first study to our knowledge to assess the accuracy
of QEA, as compared with those of PSB and BAL, in the diag-
nosis of severe NHAP. Previous studies established that cul-
tures of tracheal aspirates in patients requiring mechanical
ventilation for longer than 48 hours may not be accurate [20].
Figure 1
Receiver operator characteristic curve of QEA for the diagnosis of  pneumonia Receiver operator characteristic curve of QEA for the diagnosis of 
pneumonia. QEA, quantitative endotracheal aspirate.
Figure 2
Correlation between quantitative cultures of endotracheal aspirate and  BAL specimens Correlation between quantitative cultures of endotracheal aspirate and 
BAL specimens. The correlation coefficient (r) is 0.77 (P < 0.001). 
BAL, bronchoalveolar lavage; cfu, colony-forming units; QEA, quantita-
tive endotracheal aspirate.
Figure 3
Correlation between quantitative cultures of endotracheal aspirate and  PSB specimens Correlation between quantitative cultures of endotracheal aspirate and 
PSB specimens. The correlation coefficient (r) is 0.71 (P < 0.001). 
PSB, protected specimen brush; cfu, colony-forming units; QEA, quan-
titative endotracheal aspirate.Available online http://ccforum.com/content/11/3/R57
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Although negative cultures may have high predictive value, the
rate of false-positive results can be high, leading to over-diag-
nosis of pneumonia and misdiagnosis of etiology. Similarly,
quantitative cultures of tracheal aspirates have also yielded
mixed results. In intubated patients suspected with nosoco-
mial pneumonia, a colony count ≤ 104 cfu/ml was found in
80% of patients with clinical pneumonia but also in 61% of
patients without obvious pneumonia [11]. These findings stem
from the fact that endotracheal tube colonization and biofilm
formation occurs in many patients undergoing mechanical
ventilation from an early stage. The absence of such a risk fac-
tor would minimize the risk for tracheal aspirate contamination,
resulting in improved diagnostic accuracy. Indeed, at a thresh-
old of 104 cfu/ml, we were able to demonstrate good sensitiv-
ity (90%), specificity (77%), and negative predictive value
(80%) for QEA as compared with BAL and PSB. It is notewor-
thy that one-third of our patients had received antibiotics
before samplings, which could be regarded as a potential bias
because it could have led to a high rate of false-negative
results. Lowering the threshold value has been proposed as an
alternative for patients receiving antibiotic therapy in patients
suspected of having ventilator-associated pneumonia [21]. In
this study we were unable to confirm this approach, in part
because of the lack of histopathologic specimens.
One of the major advantages of endotracheal cultures is that
they exclude certain types of infection when the organism is
absent [22]. For example, absence of Pseudomonas in an
endotracheal aspirate makes it unlikely that this organism is
the cause of an infection. Conversely, it could be argued that
the lack of micro-organisms on Gram staining in nursing home
patients suspected of having NHAP might suggest the pres-
ence of atypical pathogens. Although outbreaks of pneumonia
caused by atypical pathogens can occur among nursing home
residents, the incidence of these infections is relative low in
this population [5,23]. Nonetheless, appropriate testing
should be performed and empiric coverage should be pro-
vided when it is highly suspected.
This study has a number of strengths, including use of each
patient as his or her own control and using explicitly defined
criteria for quantitative culture positivity. However, it has a
number of limitations, as do all studies in this discipline. We
relied upon bronchoscopic techniques (PSB and BAL) as
gold standards, but these methods are not 100% sensitive or
specific. It has been suggested that only the combined results
of histologic examination and quantitative cultures of lung tis-
sue are sufficiently powerful to rule in or rule out the presence
of pneumonia. Clearly, such a highly invasive sampling
approach would not be practical in a frail population. Without
an indisputable and easily obtainable reference, calculations
of sensitivity and specificity will remain problematic. Finally, the
impact of QEA findings on antibiotic therapy and patient out-
comes was not assessed. Pending further validation, we
thought it would be too premature to make any antibiotic rec-
ommendation for the management of severe NHAP based on
the present study alone.
Conclusion
The present study shows that QEA using a cutoff point of 104
cfu/ml represents a practical diagnostic method in patients
with severe NHAP. This modality may be useful as a first line
technique for intubated NHAP patient with clinical suspicion
of pneumonia when it is more convenient to perform prior to
administration of antibiotic therapy.
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